TGFB1 and esophageal adenocarcinoma: In accordance with published data, we observed a high abundance of TGFβ in tumor and stromal compartments of gastric cancer, esophageal adenocarcinoma, and PDAC, and the inclusion of this armoring approach increased CAR-T potency in vitro and in vivo against model systems of these indications.